Kevzara subcutaneous injection 200mg autoinjector, manufactured by Sanofi, contains Sarilumab (genetical recombination) (YJ code: 3999444G4021, 200mg 1.14mL 1 kit). It is an IL-6 receptor antagonist used for moderately to severely active rheumatoid arthritis in adults with inadequate response or intolerance to other DMARDs.
Kevzara subcutaneous injection 200mg autoinjector
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →